Scientific Integrity
Supporting decisions with sound scientific reasoning and evidence.
Independent consulting and investment
Connecting healthcare innovation with clinical development, scientific rigor and regulatory confidence.
Supporting decisions with sound scientific reasoning and evidence.
Promoting responsible clinical research and compliant practices.
Bringing together the right expertise, services and technologies to address customer needs.
About us
LEO Clinical Research LLP was established in August 2023 to help organizations navigate the evolving healthcare and clinical research landscape through informed consulting, strategic partnerships and investment.
We work with product and technology companies, biopharmaceutical organizations, Clinical Research Organizations and other stakeholders. Successful clinical development needs scientific evidence, operational excellence, ethical principles, regulatory compliance and the needs of every stakeholder — brought together, not treated in isolation.
LEO is an independent consulting and investment company. We are not a CRO group brand, and we are not the direct operator of every service described on this site.
To contribute to a connected and trusted clinical research ecosystem in which scientific innovation, technology and operational expertise work together to advance healthcare.
To help healthcare and clinical research organizations make better strategic and operational decisions by combining domain expertise, consulting, technology enablement and specialist partnerships.
Acting with transparency and professional responsibility.
Promoting evidence-based approaches and sound decision-making.
Recognizing quality and regulatory responsibility as essential to clinical research.
Building productive relationships across sponsors, CROs, sites and technology providers.
Encouraging the responsible use of technology to improve clinical research processes.
Developing relationships and business capabilities that support sustainable growth.
Consulting services
We help organizations evaluate challenges, define operating models, identify appropriate technology and specialist partners, and build capabilities aligned with their clinical development objectives.
Support for regulatory pathways, clinical development requirements and the considerations that shape research planning, with early alignment between science, operations and applicable expectations.
Advice on trial operating models, execution strategies, cross-functional coordination and process optimization so activities stay aligned with study objectives.
Support for site feasibility, workflows, operational challenges, technology enablement and collaboration between sites, sponsors and CROs.
Advice on data management strategy, database design, data quality, standards alignment and technology-enabled workflows for reliable, traceable clinical data.
Help identifying and coordinating specialist capabilities for statistical strategy, analysis planning, programming and study reporting, with a focus on rigor and reproducibility.
Planning and coordination of medical writing for clinical research documentation, with emphasis on accuracy, consistency, clarity and intended scientific purpose.
Advice on selecting, integrating and adopting clinical research technologies, from electronic data capture and trial platforms to digital solutions and analytics.
Business strategy, capability development, partnership opportunities, service expansion and market positioning for sustainable growth.
Every organization has different priorities and constraints. We start by understanding those needs, then connect the right expertise, technologies and delivery partners.
Who we work with
Our role is to understand the challenge first, then identify the right combination of advice, technology and specialist expertise.
Strategic advice on product positioning, clinical research workflows, technology adoption and alignment with industry requirements.
Consulting for clinical development planning, regulatory considerations, operational strategy and access to specialist capabilities.
Advisory and partnership support for service expansion, operating models, technology integration and business development.
Support for site-centric solutions, operational improvement, technology enablement and stronger collaboration with sponsors and CROs.
Guidance on business development, partnership models, capability building and the clinical research environment.
Investments and partnerships
Alongside consulting, LEO pursues strategic investments aligned with healthcare, clinical research and technology-enabled services. These relationships support collaboration while each company’s brand and activities stay distinct.
In December 2024, LEO Clinical Research LLP acquired a 50% equity stake in Celltrove Ventures Pte Ltd, Singapore. This is a strategic ownership relationship. Celltrove is not a wholly owned subsidiary.
Celltrove Ventures operates in the healthcare and clinical research services ecosystem. The investment reflects LEO’s interest in complementary capabilities across the clinical research value chain. LEO’s own activities and those of its investee businesses remain separate.
For details of Celltrove’s services and business activities, please visit the Celltrove website.
News and insights
December 2024
LEO Clinical Research LLP announces the acquisition of a 50% equity stake in Celltrove Ventures Pte Ltd, Singapore. The investment is a milestone in LEO’s strategic investment and business development journey, and a step toward complementary capabilities in the healthcare and clinical research ecosystem.
As an independent consulting and investment company, LEO focuses on strategic advisory, industry collaboration and investments aligned with clinical research, biopharmaceutical development and healthcare technology. The equity relationship provides a foundation for collaboration and long-term value, while both organizations keep their own activities distinct.
LEO will continue to pursue relationships aligned with scientific integrity, ethical practices, quality and responsible innovation.
Founder and leadership
Founder — Healthcare and Clinical Research
LEO is led by Bhavesh Acharya, a clinical development leader with over 25 years of experience across Clinical Operations, Clinical Data Management and Biostatistics, and Clinical Trial Site Solutions in India and China.
Bhavesh is a pharmacist by education and is trained at IIM Ahmedabad and Forum Corporation (USA) in strategy, leadership and coaching. He is a global speaker at forums including SCDM (Member, Active Speaker and India Chair 2025), PHUSE, ISCR (Lifetime Member and Scientific Committee Chair for 2022, 2023 and 2024), DIA and China Clinical Trials.
Why LEO
More than 25 years of founder-level experience in healthcare and clinical research.
Connecting organizations with appropriate expertise, technology and specialist capabilities.
Evidence-based thinking, responsible practices and applicable regulatory requirements.
Complementary relationships that support capability development and long-term value.
Contact
Whether you are exploring a clinical research challenge, evaluating a technology, expanding service capabilities or seeking a strategic partner, meaningful collaboration starts with understanding your objectives.
Independent consulting and investment company
A-4, Prayagraj Apartments, Near Krupa Petrol Pump, Ambawadi, Ahmedabad 380006, Gujarat, India
Connect with us to discuss